SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing high trading volume and active community sentiment as investors focus on the company's QNX software as a foundational element for physical AI and robotics, while management's upcoming investor conference appearances and share buyback program fuel speculation about future growth. The community remains highly bullish, citing recent institutional accumulation and the potential for a long-term turnaround as BlackBerry expands its role in mission-critical embedded systems.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as investors weigh an earnings beat against concerns over a sluggish housing market and reduced consumer spending. The community is actively debating the stock's future, with many highlighting its role as a key barometer for the broader economy while tracking its potential for a reversal.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently surging due to a combination of strong institutional buy-in ahead of upcoming earnings and recent reports regarding the approval of H200 chip sales to major Chinese technology firms. The community remains heavily divided between bullish investors who view the company's AI-driven growth as a fundamental long-term opportunity and skeptical voices who fear the stock's massive market capitalization may indicate a speculative bubble that is vulnerable to a post-earnings sell-the-news event.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently trending as investors digest their recent earnings report, with the community actively debating the company's long-term commercial potential against significant operational expenses. Despite a volatile share price, supporters are pointing to raised revenue guidance, key defense contract wins, and a robust cash position as reasons for bullish conviction.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors anticipate a major data readout at the upcoming AUA Annual Meeting, with the community closely tracking whether the extended follow-up data for CAN-2409 will confirm its potential as a practice-changing prostate cancer therapy. The stock is seeing heightened engagement from retail investors hopeful for a premium acquisition, even as discussions continue regarding institutional accumulation by firms like RTW and the potential impact of high short interest on near-term volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying following a strategic partnership with Lumilens that includes an initial purchase order and a roadmap potentially reaching half a billion dollars in sales. The community is actively debating the stock's massive institutional volume and price action, with bulls pointing to the validation of the company's photonics technology while some skeptical traders warn of the risks associated with the deal's warrant structure and potential dilution.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors digest conflicting reports regarding potential jet orders from China amid high-level trade discussions, with the community split between skepticism over deal details and long-term optimism driven by a massive backlog and production recovery. Market participants are actively debating whether the recent share price volatility represents a genuine disappointment over order volume or an overreaction driven by algorithmic trading and profit-taking.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently trending following a strong quarterly earnings report that featured a revenue and EPS beat alongside a raised outlook for the semiconductor equipment market, signaling sustained growth driven by AI infrastructure demand. The community is actively discussing the company's upgraded price targets from multiple major analyst firms and debating the durability of the AI supercycle versus potential valuation concerns.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is rallying following a strategic $100 million investment from Winklevoss Capital, which has fueled community speculation about a potential short squeeze given the stock's elevated short interest. Investors are closely weighing this capital infusion and stronger-than-expected earnings against ongoing concerns regarding the company's long-term path to profitability and recent legal challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Get Free Report) have received an average recommendation of "Moderate Buy" from the twelve analysts that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating, seven have given a buy rating and...

What is HC Wainwright's Forecast for Genmab A/S Q2 Earnings?

Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) - Research analysts at HC Wainwright boosted their Q2 2026 earnings per share estimates for shares of Genmab A/S in a report released on Thursday, April 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings o...

Oppenheimer Asset Management Inc. Acquires 48,894 Shares of Genmab A/S Sponsored ADR $GMAB

Oppenheimer Asset Management Inc. raised its holdings in shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) by 15.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 364,756 shares of the company's stock after...

Genmab A/S (OTCMKTS:GNMSF) Sees Strong Trading Volume  - Still a Buy?

Genmab A/S (OTCMKTS:GNMSF) Sees Large Volume Increase - Should You Buy...

HC Wainwright Has Lowered Expectations for Genmab A/S (NASDAQ:GMAB) Stock Price

HC Wainwright reduced their price target on Genmab A/S from $40.00 to $38.00 and set a "buy" rating for the company in a report on Thursday...

Genmab A/S (GMAB) Projected to Post Earnings on Thursday

Genmab A/S (NASDAQ:GMAB) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...

Pictet Asset Management Holding SA Takes $33.84 Million Position in Genmab A/S Sponsored ADR $GMAB

Pictet Asset Management Holding SA bought a new position in shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,098,550 shares of the company's stock, valued at approximatel...

Genmab A/S (GNMSF) Expected to Announce Quarterly Earnings on Thursday

Genmab A/S (OTCMKTS:GNMSF) will be releasing earnings on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-genmab-as-stock-1...

Genmab A/S (OTCMKTS:GNMSF) Short Interest Up 25.8% in April

Genmab A/S (OTCMKTS:GNMSF - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totaling 120,139 shares, an increase of 25.8% from the March 31st total of 95,479 shares. Based on an average daily volume...

ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View

AbbVie tops Q1 estimates on strong Rinvoq and Skyrizi sales, lifts 2026 EPS outlook and gains premarket despite continued Humira and Imbruvica declines.

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Current Price	$26.90
Prev Close	$26.55
Open	$26.82
Dividend Yield	0.00%
50-Day Moving Average	$27.03
Beta	0.67
Avg. Volume	1.6M
PE Ratio	20.09

52-Week High	$35.43
52-Week Low	$19.59
Market Capitalization	$16B
EPS (Annual)	$1.55
Price to Book	2.91
Revenue Per Employee	$1.23M

GMAB
Genmab - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GMAB News

GMABGenmab - ADR